Read our latest advice on Coronavirus (COVID-19)

Our services are open and safe to attend – we are here to help

Gennatas, Spyros - consultant medical oncologist


Consultant profiles


spyros-gennatasMedical secretary: Klementina Cumraku
Tel: 020 7188 7188 ext 56079
Referral email:
Enquiries email:

Area of expertise: Treatment of thoracic cancers: lung cancer, mesothelioma, and thymic epithelial tumours; acute oncology

  • Biography

    Spyros Gennatas has been a consultant medical oncologist at Guy's and St Thomas' hospital NHS Foundation Trust since 2021. He specialises in the treatment of thoracic malignancies, including lung cancer, thymic epithelial tumours and mesothelioma. He also works as a member of the acute oncology service at St Thomas' Hospital.

    Spyros completed his medical oncology training at the Royal Marsden Hospital. He was awarded a PhD in the 'Genetic alterations leading to thymic epithelial malignancies', by Imperial College London (ICL) in 2018. During that time, he also worked as a research fellow for the National Mesothelioma Centre at ICL. He has published in high-impact, peer-reviewed journals and presented in international meetings in the fields of molecular genetics, quality of life in cancer patients, Covid-19 and cancer, and medical oncology.

  • Education

    • 2019 – Certificate of completion of training in medical oncology, The Royal  Marsden Hospital

    •  2018 – PhD, National Heart and Lung Institute, Imperial College, London

    •  2014 – Specialty certificate in medical oncology, Royal College of Physicians and the Association of Cancer Physicians

    •  2013 – Postgraduate diploma in oncology, Institute of Cancer Research

    •  2010 – MRCP UK (London), Royal College of Physicians

    •  2006 – Medicine MBChB, University of Leicester and University of Warwick

    •  2004 – Intercalated BSc, University of Leicester

  • Awards

    2003 – Jean Shanks Award; This is awarded to a student undertaking a pathological-based intercalated BSc project according to their academic performance and the quality of the research project

  • Specialist interests

    • Lung cancer

    • Thymic epithelial tumours

    • Mesothelioma

    • Targeted therapies and immunotherapy

    • Clinical genetics

    • Quality of life

    • Acute oncology

  • Research interests

    Spyros Gennatas' research interests include the development of novel therapeutic agents for the treatment of thoracic cancers, including lung cancer, thymic epithelial tumours and mesothelioma though clinical trials and translational research as well as the development of predictive and prognostic biomarkers.